Appointments

The International Drug Development Institute (IDDI) has announced changes to its executive leadership team to strengthen the company’s leadership and operational capabilities.

Tim Davis has been announced as chief executive officer, bringing over 25 years of experience to the role. Tim has previously worked in the pharmaceutical, life sciences and digital health sectors, leading strategic initiatives at Veeva Systems and co-founding Exco InTouch – a patient engagement and data capture company. He has held digital patient engagement and eClinical leadership roles.

With over 27 years of experience across the clinical development sector, Jeremy Edwards has been appointed to chief commercial officer. He has held executive leadership roles in full-service CROs and specialised eClinical service providers. Jeremy also worked alongside Tim Davis at Exco InTouch.

Marc Buyse, founder and chief scientific officer of IDDI, stated: “Tim’s wealth of managerial and operational expertise combined with Jeremy’s commercial and marketing experience will broaden our strategic leadership and operational excellence at IDDI. Their proven track record of working together will play a key role in strengthening our patient-centric solutions. By collaborating with our sister company, One2Treat, we intend to further innovate these solutions, focusing on integrating key patient-relevant outcomes to enhance treatment decisions and market access evaluations.”